Accelerating Data Solutions to Save LIVES from COVID-19

The consortium of COVID-X announces the launch of the ​1st Open Call ​framed in a ​2-year initiative that will invest ​4 million € to fast-track to market 30+ European data technology solutions defeating COVID-19 Challenges, facilitating an innovative stack of AI-driven tools.

COVID-19 pandemic is hitting with force. Europe has passed the threshold of ​250,000 deaths since February 2020.​ COVID-X takes the battle against corona virus to a new level by bridging the gap between the European digital sector and the healthcare system. The program will unlock the full capacity of Artificial Intelligence and Data to fight COVID-19​, validating, and scaling up breakthroughs to save lives.

COVID-X will fund EU Companies and Healthcare Providers to boost data-driven solutions with the power to overcome challenges in Diagnosis, Prognosis, and Follow-up. The funding is invested in products with TRL7+ and [or in the process of] CE marking, covering two profiles: single players (EU Tech SMEs / Start-Ups) validating their solutions at one of COVID-X clinical partners; or ​multiplayers (Tech Provider working with a Healthcare provider that will validate the solution). The selected projects will join an Acceleration Program to boost their quick market uptake. ​This will include technical support, ethical validation, and business coaching.

In addition, participants will have access to the ​COVID-X Sandbox​, a one-stop platform to exploit COVID-19 data sources, incorporating general information on data silos, as well as the integration, visualization, and exploratory analysis for easy understanding. The 1st Open Call Application is now open and the deadline will be on​ the 27th January 2021.

For further information, please visit:
https://www.covid-x.eu

Most Popular Now

CSAM Acquires Optima - Further Boosts eH…

CSAM Health Group AS ("CSAM"), the leading provider of niche eHealth solutions in the Nordics, today announced it has signed a deal to acquire eHealth player Optima Corporation Ltd from...

Using Artificial Intelligence to Overcom…

Depression is a worldwide problem, with serious consequences for individual health and the economy, and rapid and effective screening tools are thus urgently needed to counteract its increasing prevalence. Now...

EU Digital COVID Certificate Enters into…

The EU Digital COVID Certificate Regulation enters into application. This means that EU citizens and residents will now be able to have their Digital COVID Certificates issued and verified across...

Deep Machine Learning Completes Informat…

The Structural Bioinformatics and Network Biology laboratory, led by ICREA Researcher Dr. Patrick Aloy, has completed the bioactivity information for a million molecules using deep machine-learning computational models. It has...

Scottish Health and Care Professionals G…

Scottish health and care professionals across a wide range of clinical settings including NHS Scotland health boards are being given access to an individual's COVID-19 vaccine status through the Orion...

Philips and the Spanish National Center …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has participated in an important research project to develop a magnetic resonance (MR) imaging technique [1,2] that could...

Ethics and Governance of Artificial Inte…

Artificial Intelligence (AI) refers to the ability of algorithms encoded in technology to learn from data so that they can perform automated tasks without every step in the process having...

It's Going to be Quite a Handover…

Health and social care secretary Matt Hancock has been abruptly replaced by Sajid Javid. The Highland Marketing advisory board consider the huge agenda he is now facing, and what it...

Philips Accelerates Stroke Diagnosis and…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced a strategic partnership agreement with NICO.LAB, a MedTech stroke care company. Together with the recently expanded stroke...

Open Call HORIZON-HLTH-2021-TOOL-06-01: …

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 5 "Unlocking the full potential of new tools, technologies and digital...

Exscientia Accelerates COVID-19 Drug Dis…

Exscientia has received a grant from the Bill & Melinda Gates Foundation and Gates Philanthropy Partners, as part of the COVID-19 Therapeutics Accelerator. This is to expedite the optimisation of...

Smartphone Photos can be Used to Detect …

A picture of a person's inner eyelid taken with a standard smartphone camera can be used to screen for anemia, according to a new study published this week in the...